Companies
We are proud to be among the first investors and long-term partners to industry leaders who are empowering individuals and businesses through the innovative use of AI and other transformative technologies.
Segmed
Secure cloud-based platform provides high quality data for medical AI development
Segmed, Inc. collaborates with life sciences, healthcare, and technology leaders to streamline access to diverse, high-quality medical imaging studies for biopharmaceutical R&D, AI development, and medical device innovation. With a global network of healthcare partners across five continents, Segmed provides researchers with over 100 million de-identified, standardized imaging datasets through its proprietary platform—empowering safer, faster, and more equitable healthcare advancements.
Blumberg Capital last invested in Segmed in April 2024.